Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
All content for The MTPConnect Podcast is the property of MTPConnect and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
How the UK’s Subscription-Style Model is Improving Access to Much-Needed Antibiotics
The MTPConnect Podcast
17 minutes
11 months ago
How the UK’s Subscription-Style Model is Improving Access to Much-Needed Antibiotics
As World Antimicrobial Resistance Awareness Week (WAAW) kicked off around the globe, the Australian Antimicrobial Resistance Network (AAMRNet) was meeting in Canberra to explore how Australia can better support the development of and access to new antimicrobial technologies. Key clinicians, researchers, industry and government representatives gathered to discuss how a subscription-style funding model for new antimicrobials might be adapted to be fit-for-purpose in Australia.It’s an idea ...
The MTPConnect Podcast
Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
